WASHINGTON (dpa-AFX) - Artiva Biotherapeutics, Inc. (ARTV) announced the pricing of its upsized initial public offering of about 13.92 million shares of common stock at a price to the public of $12.00 per share.
The company expects gross proceeds from the offering to be approximately $167.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the company.
In addition, Artiva has granted the underwriters a 30-day option to purchase up to an additional 2.09 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.
The shares are expected to begin trading on the Nasdaq Global Market on July 19, 2024, under the symbol 'ARTV.'
The offering is expected to close on July 22, 2024.
Jefferies, TD Cowen and Cantor are acting as joint book-running managers for the offering. Wedbush PacGrow and Needham & Company are acting as co-lead managers for the offering.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2024 AFX News
